Question Description
Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to:a)7 ng/ml.b)9 ng/ml.c)11 ng/ml.d)16 ng/ml.Correct answer is option 'C'. Can you explain this answer? for ACT 2025 is part of ACT preparation. The Question and answers have been prepared according to the ACT exam syllabus. Information about Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to:a)7 ng/ml.b)9 ng/ml.c)11 ng/ml.d)16 ng/ml.Correct answer is option 'C'. Can you explain this answer? covers all topics & solutions for ACT 2025 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to:a)7 ng/ml.b)9 ng/ml.c)11 ng/ml.d)16 ng/ml.Correct answer is option 'C'. Can you explain this answer?.

Solutions for Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to:a)7 ng/ml.b)9 ng/ml.c)11 ng/ml.d)16 ng/ml.Correct answer is option 'C'. Can you explain this answer? in English & in Hindi are available as part of our courses for ACT. Download more important topics, notes, lectures and mock test series for ACT Exam by signing up for free.

Here you can find the meaning of Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to:a)7 ng/ml.b)9 ng/ml.c)11 ng/ml.d)16 ng/ml.Correct answer is option 'C'. Can you explain this answer? defined & explained in the simplest way possible. Besides giving the explanation of Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to:a)7 ng/ml.b)9 ng/ml.c)11 ng/ml.d)16 ng/ml.Correct answer is option 'C'. Can you explain this answer?, a detailed solution for Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to:a)7 ng/ml.b)9 ng/ml.c)11 ng/ml.d)16 ng/ml.Correct answer is option 'C'. Can you explain this answer? has been provided alongside types of Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to:a)7 ng/ml.b)9 ng/ml.c)11 ng/ml.d)16 ng/ml.Correct answer is option 'C'. Can you explain this answer? theory, EduRev gives you an ample number of questions to practice Directions:Read the passages and choose the best answer to each question.PassageResearchers conducted trials on a certain prescription drug delivered in immediate-release capsules and extended-release capsules.Figure 1 shows the mean concentration (nanograms per milliliter [ng/mL]) of the two active ingredients of the prescription drug in patients’ blood plasma over time (hr).In clinical trials of the prescription drug, subjects given the prescription drug were interviewed at regular intervals about the symptoms the prescription drug is meant to relieve.After each interview, the subjects were assigned a symptom score. A high symptom score corresponds to high intensity of symptoms, and a low symptom score indicates low intensity of symptoms. Figure 2 shows the mean symptom score over time (hr) for subjects who took the prescription drug.In the clinical trials, some subjects were given the prescription drug and some subjects were given a placebo (an inactive pill). Table 1 shows the percentage of subjects from both groups who reported various adverse side effects.Q.According to Figure 1, 16 hours after taking the extended-release form of the prescription drug, the difference in mean blood plasma concentration between Ingredient A and Ingredient B is closest to:a)7 ng/ml.b)9 ng/ml.c)11 ng/ml.d)16 ng/ml.Correct answer is option 'C'. Can you explain this answer? tests, examples and also practice ACT tests.